Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2025-12-24 @ 2:01 PM
NCT ID:
NCT02021695
Eligibility Criteria:
Inclusion Criteria:
1. Must provide informed consent
2. Males or Females aged 30 years or older to minimize the potential confounding of other forms of diabetes mellitus
3. In patients with diabetes, no concomitant diseases except for micro- and macrovascular complications of diabetes (nephropathy, retinopathy, peripheral arterial disease, coronary artery disease, neuropathy) or symptoms of the metabolic syndrome (hypertension, dyslipidemia and obesity)
4. Not taking any chronic medications (except of the diabetes and cardiovascular related drugs).
Exclusion Criteria:
1. Diagnosis of Type-I Diabetes
2. Active situational diabetes (steroids use/pregnancy)
3. Active infection or acute illness of any kind
4. Chronic inflammation (auto-immune diseases) or infection
5. Evidence of malignancy within the past 5 years
6. Chronic hematological disorders known to affect glycated hemoglobin results such as hemoglobinopathies (e.g. sickle cell disease and thalassemia), increases red-cell turnover (e.g. hemolytic anemia and spherocytosis.
* Evidence of malignancy within the past 5 years
* Chronic hematological disorders known to affect glycated hemoglobin results such as hemoglobinopathies
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT02021695
Study Brief:
Protocol Section:
NCT02021695